Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,674,039 | 1,272,676 | 1,506,835 | 1,365,980 | 1,215,529 |
| Cost of Goods | 104,957 | 104,523 | 121,175 | 99,001 | 78,766 |
| Gross Profit | 1,569,082 | 1,168,153 | 1,385,660 | 1,266,979 | 1,136,763 |
| Operating Expenses | 872,141 | 867,559 | 1,049,976 | 823,462 | 607,215 |
| Operating Income | 697,898 | 301,117 | 335,859 | 443,518 | 530,314 |
| Interest Expense | 582 | 569 | 582 | 592 | 594 |
| Other Income | 54,198 | 43,052 | 54,664 | 39,382 | 28,292 |
| Pre-tax Income | 751,514 | 343,600 | 389,941 | 482,308 | 558,012 |
| Income Tax | 165,909 | 40,270 | 90,662 | 58,139 | 153,013 |
| Net Income Continuous | 585,605 | 303,330 | 299,279 | 424,169 | 404,999 |
| Net Income | $585,605 | $303,330 | $299,279 | $424,169 | $404,999 |
| EPS Basic Total Ops | 2.92 | 1.52 | 1.51 | 2.17 | 2.09 |
| EPS Basic Continuous Ops | 2.92 | 1.52 | 1.52 | 2.17 | 2.09 |
| EPS Diluted Total Ops | 2.81 | 1.47 | 1.46 | 2.11 | 2.04 |
| EPS Diluted Continuous Ops | 2.81 | 1.47 | 1.47 | 2.11 | 2.04 |
| EPS Diluted Before Non-Recurring Items | 2.80 | 1.55 | 1.56 | 2.03 | 1.31 |
| EBITDA(a) | $724,374 | $324,919 | $359,841 | $467,541 | $553,233 |